Latest antibodies Stories
QUEBEC CITY, Feb.
Approval Significantly Expands U.S. Market for INSTI(TM) HIV-1/2 Test RICHMOND, BC, Feb.
ALBUQUERQUE, N.M., Feb. 17, 2015 /PRNewswire/ -- Agilvax, Inc.
MONROVIA, Calif., Feb. 12, 2015 /PRNewswire/ -- Xencor, Inc.
LONDON, February 11, 2015 /PRNewswire/ -- Report Details Biosimilar therapeutic antibodies - see why originator companies should now fear those competitors,
MBS acquired an MTI seed grant with the intent to integrate the antibodies into a lateral flow, point of care test to measure both equine progesterone and LH as a method of predicting ovulation
MONROVIA, Calif., Feb. 5, 2015 /PRNewswire/ -- Xencor, Inc.
-33% rate of DAS28-CRP remission or low disease activity reported in Phase 2a cohort- MONROVIA, Calif., Jan. 29, 2015 /PRNewswire/ -- Xencor, Inc.
- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,
PLANTATION, Fla., Jan.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.
More Images (1 images) »